2 active not recruiting, 2 recruiting, 1 terminated. 2 Not applicable, 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Active not recruiting 1, Recruiting 1 |
| Phase 1 | 2 | Active not recruiting 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Metastatic Liver Carcinoma: new trials by email Literature Review of Metastatic Liver Carcinoma trials Research Report on Metastatic Liver Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform Biospecimen Collection, Tissue Collection - Early Stage Triple-Negative Breast Carcinoma, Metastatic Bladder Urothelial Carcinoma | Recruiting | Mayo Clinic | 324 | 2024-04-24 | 2026-03-12 | |
| Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events Best Practice, Patient Monitoring, Questionnaire Administration - Clinical Stage IV Esophageal Adenocarcinoma AJCC v8, Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8 | Not applicable | Active not recruiting | M.D. Anderson Cancer Center | 750 | 2021-05-12 | 2026-06-16 |
| Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies Anti-CTLA4 Monoclonal Antibody BMS-986218, Nivolumab, Stereotactic Body Radiation Therapy - Advanced Lung Carcinoma, Advanced Malignant Solid Neoplasm | Phase 1 / Phase 2 | Terminated | M.D. Anderson Cancer Center | 13 | 2021-03-29 | 2026-03-03 |
| Intravital Microscopy in Human Solid Tumors Diagnostic Microscopy, Fluorescein Sodium Injection - Solid Tumor, Adult, Clinical Stage IV Gastric Cancer AJCC v8 | Not applicable | Recruiting | Mayo Clinic | 85 | 2019-02-28 | 2026-06-02 |
| Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer Angiography, Computed Tomography, Planar Imaging - Metastatic Liver Carcinoma, Stage IV Liver Cancer | Phase 1 | Active not recruiting | M.D. Anderson Cancer Center | 12 | 2017-01-09 | 2026-09-16 |
Carcinoma, Hepatocellular (5) · Colorectal Neoplasms (2) · Esophageal Neoplasms (2) · Liver Neoplasms (2) · Neoplasm Metastasis (2) · Pancreatic Neoplasms (2) · Stomach Neoplasms (2) · Adrenal Gland Neoplasms (1) · Brain Neoplasms (1) · Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Carcinosarcoma (1) · Cholangiocarcinoma (1) · Clear-cell metastatic renal cell carcinoma (1)
Adenocarcinoma (5) · Carcinoma (5) · Digestive System Diseases (5) · Digestive System Neoplasms (5) · Liver Diseases (5) · Neoplasms (5) · Neoplasms by Histologic Type (5) · Neoplasms by Site (5) · Neoplasms, Glandular and Epithelial (5) · Colonic Diseases (3) · Endocrine Gland Neoplasms (3) · Endocrine System Diseases (3) · Gastrointestinal Diseases (3) · Intestinal Diseases (3) · Intestinal Neoplasms (3)
Blood Specimen Collection (1) · Cerebral Angiography (1) · Fluorescein (1) · Fluoresceins (1) · Nivolumab (1) · Photons (1) · Practice Guidelines as Topic (1) · Radiosurgery (1) · Remote Patient Monitoring (1) · Specimen Handling (1) · Standard of Care (1) · Technetium Tc 99m Aggregated Albumin (1) · Tissue Banks (1) · X-Rays (1)
M.D. Anderson Cancer Center (3) · Mayo Clinic (2)
United States (5)
Armeen Mahvash (1) · Dev Mukhopadhyay, PhD (1) · Emmanuel M Gabriel, M.D., Ph.D. (1) · James Welsh (1) · Ryan W Huey, MD (1)
PMID 12001988, PMID 17704903, PMID 19906081, PMID 19917863, PMID 20061178, PMID 20233873, PMID 20336386, PMID 20374484, PMID 20490982, PMID 20737573, PMID 21153378, PMID 21909917, PMID 21926464, PMID 22162570, PMID 23456602, PMID 24956510, PMID 25013744, PMID 26883450, PMID 2801858, PMID 33654117, PMID 36821818, PMID 37124504, PMID 3808620, PMID 40791544, PMID 41484629
P30CA016672 (1)